

Publisher: Karger
E-ISSN: 1421-9824|28|4|288-294
ISSN: 1420-8008
Source: Dementia and Geriatric Cognitive Disorders, Vol.28, Iss.4, 2009-10, pp. : 288-294
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Dementia and Geriatric Cognitive Disorders, Vol. 32, Iss. 6, 2012-02 ,pp. :




Galantamine for Alzheimer’s Disease and Mild Cognitive Impairment
Neuroepidemiology, Vol. 28, Iss. 2, 2007-04 ,pp. :